Saggar Rajeev Insider Trading -- Recent SEC Form 4 Transactions

Saggar Rajeev (CIK 1935638) reported 27 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-19). Recent activity: Sell LQDA (29,534 shares), Buy LQDA (50,000 shares), Sell LQDA (50,000 shares), Buy LQDA (3,531 shares), Buy LQDA (4,487 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-08-19Liquidia Corp (LQDA)Chief Medical OfficerSell29,534$2.3M
2026-08-19Liquidia Corp (LQDA)Chief Medical OfficerBuy50,000$186,500
2026-08-19Liquidia Corp (LQDA)Chief Medical OfficerSell50,000$3.7M
2026-07-14Liquidia Corp (LQDA)Chief Medical OfficerBuy3,531$0
2026-07-14Liquidia Corp (LQDA)Chief Medical OfficerBuy4,487$0
2026-07-14Liquidia Corp (LQDA)Chief Medical OfficerSell703$50,187
2026-07-14Liquidia Corp (LQDA)Chief Medical OfficerSell9,223$659,629
2026-04-14Liquidia Corp (LQDA)Chief Medical OfficerBuy3,531$0
2026-04-14Liquidia Corp (LQDA)Chief Medical OfficerBuy4,486$0
2026-04-14Liquidia Corp (LQDA)Chief Medical OfficerSell9,220$353,771
2026-03-17Liquidia Corp (LQDA)Chief Medical OfficerSell35,365$1.3M
2026-01-21Liquidia Corp (LQDA)Chief Medical OfficerBuy32,955$0
2026-01-13Liquidia Corp (LQDA)Chief Medical OfficerBuy3,531$0
2026-01-13Liquidia Corp (LQDA)Chief Medical OfficerBuy17,945$0
2026-01-13Liquidia Corp (LQDA)Chief Medical OfficerSell21,142$791,345
2025-11-07Liquidia Corp (LQDA)Chief Medical OfficerSell4,918$132,786
2025-11-07Liquidia Corp (LQDA)Chief Medical OfficerSell66,463$1.8M
2025-10-15Liquidia Corp (LQDA)Chief Medical OfficerBuy3,530$0
2025-10-15Liquidia Corp (LQDA)Chief Medical OfficerSell5,327$124,705
2025-09-02Liquidia Corp (LQDA)Chief Medical OfficerSell20,000$557,000
2025-07-23Liquidia Corp (LQDA)Chief Medical OfficerSell2,526$36,728
2025-07-15Liquidia Corp (LQDA)Chief Medical OfficerBuy3,531$0
2025-07-15Liquidia Corp (LQDA)Chief Medical OfficerSell5,327$76,070
2025-06-05Liquidia Corp (LQDA)Chief Medical OfficerBuy17,654$0
2025-06-05Liquidia Corp (LQDA)Chief Medical OfficerSell7,597$128,921

Source: SEC Form 4 filings · as of 2026-08-19